Document is current
Any future updates will be listed below
-
Authors
Vaishnav, Eeshit Dhaval https://orcid.org/0000-0003-3720-8051
de Boer, Carl G. https://orcid.org/0000-0001-8935-5921
Molinet, Jennifer https://orcid.org/0000-0001-9716-4455
Yassour, Moran
Fan, Lin
Adiconis, Xian
Thompson, Dawn A.
Levin, Joshua Z. https://orcid.org/0000-0002-0170-3598
Cubillos, Francisco A. https://orcid.org/0000-0003-3022-469X
Regev, Aviv https://orcid.org/0000-0003-3293-3158
- License Information
-
More Information
Article History
Received: 8 February 2021
Accepted: 2 February 2022
First Online: 9 March 2022
Competing interests
: A.R. is a co-founder and equity holder of Celsius Therapeutics and Immunitas and until 31 July 2020 was a member of the scientific advisory board of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov. As of 1 August 2020, A.R. is an employee of Genentech. The other authors declare no competing interests.
